Heath promotion tobacco use in copd patients

  i have attached guidelines, rubric, and outline it is to be written by. Headings must match rubric so they may need modified from outline. I. Introduction For my health promotion project I chose tobacco use specifically related to patients with COPD. Many people suffer with COPD and continue to smoke not realizing the increased risk in disease progression. I have worked with many patients with COPD as well as family members who continue to smoke. This subject is not only important to me as a nurse but on a personal level as well. A. Program Mission The purpose of this initiative is to ensure all patients understand the effects of smoking on the progression of COPD in an effort to decrease the use of tobacco among the chosen population. B. Target Population My chosen target population are COPD patients who continue to smoke ages 65 and older. II. Clinical Significance Smokers are at high risk for lung disease such as COPD and tobacco use is directly related to COPD related deaths. Studies have shown a decrease in the progression of COPD in patients who stop smoking. Hence, patients who stop smoking have overall healthier outcomes than those who do not. A. Client & Community Studies have shown that 50% of smokers eventually develop COPD. Smoking use is responsible for 80% of COPD-related deaths. B. Health Care System Continued smoking is extremely expensive to the patient as well as insurance providers. Consultations rates in primary care offices have increased dramatically due to COPD exacerbations. Also, hospital admissions are on the rise with one of the most common causes due to COPD exacerbations. III. Program for Prevention Smoking tobacco is responsible for approximately 90 percent of COPD diagnosis. While COPD is not reversible, it is preventable and treatable. The best course of action for treatment consists of 90% education and 10% medication. The primary goal for smokers who have been diagnosed with COPD is smoking cessation. A. Goals The first line of defense in smoking cessation begins with the patient by determining his or her readiness to quit. The implementation of evidence based education techniques are crucial in gaining smoking cessation compliance. Education begins with the primary care provider and should include information on the progression of the disease and its direct relation to tobacco smoking. Also, it is crucial to highlight facts such as the ability to slow the disease with smoking cessation compliance. Continued efforts are followed up by home healthcare agencies to assist patients with the efforts to stop smoking. Motivation through family support as well as seeking assistance from licensed therapists and or psychologist are important. The initiation of medications by primary care providers, such as nicotine supplements and Wellbutrin are highly recommended especially with patients who are long term and or heavy smokers. B. Organizations According to the CDC, there are multiple organizations available to assist patients with smoking cessation. International organizations include: International Union Against Cancer, Region of the Americas, The World Bank: Economics of Tobacco Control and World Health Organization (WHO): Tobacco Free Initiative. The WHO is probably the most notable organization known for its efforts to stop smoking. According to the WHO initiative, with education and medication, the chances of a smoker quitting smoking more than doubles. IV. Resources Resources include: motivational interviewing, home health care, physician education on medications as well as therapies, social support online sites, questionnaires, licensed therapist and psychologists, and pamphlets on smoking cessation and COPD. Many resources are available through the primary care provider. Also, resources are available for those without health care coverage depending on the are one lives. The CDC offers a list of free quit smoking support such as smokefree.gov, quitline, and American Cancer Society. V. Barriers The number one barrier to smoking cessation is the failure to want to quit. For many, the addiction is so great, he or she does not have the will power to quit. Other barriers to quitting smoking is lack of education, high stress levels, peer pressure, low socio-economic background weight gain, and expense related to smoking cessation aides. Primary care providers as well as the department of health can provide patients with more information to smoking cessation as well as tailoring a plan specific to the patient. VI. Summary Tobacco use is the number one risk factor for COPD. Due to the lack of education, many patients diagnosed with COPD are unaware of the harmful effects of continued smoking. Also, smokers who have been diagnosed with COPD believe smoking cessation is pointless considering the disease is already present. Patients are unaware that COPD is preventable and treatable. Help is available in many forms to educate and assist COPD patients with smoking cessation. Follow up treatments, medications, and therapeutic supports are available through healthcare providers and insurance companies. Free sources are available to those without coverage and who suffer limited income and resources. Willingness to quit is the first line of defense for every smoker. VII. References Flott, Elizabeth A. 2015. “Smoking Cessation Strategies for Patients with COPD.” Home Healthcare Now, 33(7), 375-379. doi: 10.1097/NHH.0000000000000263 Higginson, R., & Parry, A. (2018). Managing chronic obstructive pulmonary disease in the community setting. British Journal of Community Nursing, 23(1), 6-12. doi: 10.12968/bjcn.2018.23.1.6 Parker, D.R.., Eltinge, S., Raffery, C., Eaton, C.B., Clarke, J.G., & Goldman, R.E. (2015). Primary Care Providers’ Views on Using Lung Age as an Aid to Smoking Cessation Counseling for Patients with Chronic Obstructive Pulmonary Disease. Lung, 193(3), 321-327. doi: 10.1007/s00408-015-9708-8 Suhaj, A., Manu, M.K., Unnikrishnan, M.K., Vijayanarayana, K., & Malikarjuna Rao, C. (2016). Effectiveness of clinical pharmacist intervention on health- related quality of life in chronic obstructive pulmonary disorder patients – randomized controlled study. Journal of Clinical Pharmacy & Therapeutics, 41(1), 78-83. doi: 10.1111/jcpt.12353 Yazar, E. E., Sanin, F., Aynaci, E., Yildiz, P., Ozgul, A., & Yilmaz, V. (2013). The Impact of Dyspnea and Physician-based Diagnosis of Chronic Obstructive Pulmonary Disease on Smoking Cessation Behavior. Nobel Medicus Journal, 9(3), 69-73.